Narnatumab Antibody
Narnatumab (IMC-RON8) is a humanized monoclonal antibody designed to target the RON (MST1R) receptor, exhibiting antitumor activity. It is utilized in preclinical and clinical research for advanced solid tumors, with studies investigating its effects in both in vitro cellular assays and in vivo xenograft models.
Product Specifications
Product Name Alternative
LY 3012219, LY3012219, IMC-RON-8, IMCRON8, IMC-RON8, Anti-MSPR/RON/CD136 Reference Antibody
Target
C-Met/HGFR
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
3.55 mg/mL
Purity
99.57% (May vary between batches)
Molecular Weight
145.8 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1452323-01 0.02 mg (E-Coli)
Recombinant Xanthomonas oryzae pv. oryzae Alanine racemase (alr)
Sign In for Pricing
View Details MBS1452323-02 0.02 mg (Yeast)
Recombinant Xanthomonas oryzae pv. oryzae Alanine racemase (alr)
Sign In for Pricing
View Details MBS1452323-03 0.1 mg (E-Coli)
Recombinant Xanthomonas oryzae pv. oryzae Alanine racemase (alr)
Sign In for Pricing
View Details